19 June 2013
Keywords: orphan, drug, cleared, rare, liver, disease, food
Article | 28 January 2002
The US Food and Drug Administration has given marketing approval for anew orphan-designated product for hereditary tyrosinemia type I, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
18 June 2013
© 2013 thepharmaletter.com